Evoke Pharma (EVOK) News Today $5.07 -0.42 (-7.65%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.comDecember 22 at 2:19 AM | americanbankingnews.comEvoke underscores committment to patients after FDA update on domperidoneDecember 21 at 12:15 AM | markets.businessinsider.comEvoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply EndsDecember 19 at 8:30 AM | globenewswire.comEvoke Pharma (NASDAQ:EVOK) Coverage Initiated at StockNews.comDecember 16, 2024 | americanbankingnews.comEvoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting GIMOTI®December 3, 2024 | globenewswire.comEvoke Pharma Third Quarter 2024 Earnings: Misses ExpectationsNovember 10, 2024 | finance.yahoo.comEvoke Pharma Reports Q3 2024 Financial ResultsNovember 8, 2024 | markets.businessinsider.comEvoke Pharma, Inc. Reports Third Quarter 2024 Financial ResultsNovember 7, 2024 | globenewswire.comEvoke Pharma Shares Soar on Positive Data for Gimoti Nasal Treatment in Diabetic GastroparesisOctober 29, 2024 | finance.yahoo.comEvoke Pharma trading halted, volatility trading pauseOctober 29, 2024 | markets.businessinsider.comEvoke Pharma Stock Is Soaring Monday: What's Going On?October 28, 2024 | benzinga.comEvoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI®October 28, 2024 | finance.yahoo.comEvoke stock rockets 90% on study of Gimoti in GLP-1 usersOctober 28, 2024 | msn.comEvoke Pharma Shares Rise 70% on Gimoti Data in GLP-1 UsersOctober 28, 2024 | marketwatch.comEvoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific MeetingOctober 23, 2024 | globenewswire.comEvoke Pharma appoints Ben Smeal to board of directorsOctober 23, 2024 | markets.businessinsider.comEvoke Pharma Appoints Benjamin Smeal as DirectorOctober 23, 2024 | markets.businessinsider.comEvoke Pharma Announces the Appointment of Ben Smeal to the Board of DirectorsOctober 22, 2024 | globenewswire.com"Clear and very legitimate interest": Blinken offers support for Israel's actions against HezbollahOctober 12, 2024 | msn.comUS announces sanctions targeting Iran's petroleum, petrochemical sectors over Israel attackOctober 12, 2024 | msn.comEvoke Pharma (NASDAQ:EVOK) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comEvoke Pharma secures $3 million from warrant exercisesOctober 3, 2024 | uk.investing.comEvoke Pharma Announces Proceeds from Existing Warrants and Board ExpansionOctober 1, 2024 | globenewswire.comAcademic fraud endemic in published research, from photoshopped blots to AI slopSeptember 28, 2024 | msn.comThe Most Famous Cafe in Paris Preps for a New GenerationSeptember 24, 2024 | nytimes.comInside Google Ventures’ first 15 years — and its plans for the next 300September 21, 2024 | msn.comNantahala Capital Management's Recent Transaction in Evoke Pharma IncSeptember 21, 2024 | finance.yahoo.comEvoke Pharma, Inc.: Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry DevelopmentsSeptember 20, 2024 | finanznachrichten.deEvoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry DevelopmentsSeptember 19, 2024 | globenewswire.comXLR8 America and EVoke Systems Partner to Deliver Smarter EV Charging Stations to the Parking IndustrySeptember 18, 2024 | businesswire.comAmit Kumar, Rocket Mondal and Rangan Chakravarty come together for a music albumSeptember 15, 2024 | msn.comEvoke Pharma to Participate in Gastroenterology and Hepatology Advanced Practice Providers (GHAPP) Annual ConferenceSeptember 9, 2024 | globenewswire.comEvoke Pharma to Present at H.C. Wainwright’s 26th Annual Global Investment ConferenceSeptember 4, 2024 | finance.yahoo.comEvoke Pharma to Present at H.C. Wainwright's 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comEvoke Pharma Inc (EV00.SG)August 24, 2024 | nz.finance.yahoo.comEvoke Pharma Second Quarter 2024 Earnings: Misses ExpectationsAugust 15, 2024 | finance.yahoo.comEVOKE PHARMA INC.DL-,0001 (EV0.F)August 14, 2024 | nz.finance.yahoo.comEVOKE PHARMA INC.DL-,0001 (EV0.MU)August 14, 2024 | nz.finance.yahoo.comEvoke Pharma, Inc. Reports Second Quarter 2024 Financial ResultsAugust 13, 2024 | globenewswire.comThe power of snake venom: The science behind nature’s deadliest toxinAugust 12, 2024 | msn.comAuxly Cannabis Group Inc (3KF.BE)August 11, 2024 | finance.yahoo.comEvoke Pharma, Inc. Supports Gastroparesis Awareness MonthAugust 8, 2024 | globenewswire.comEvoke Pharma announces 1-for-12 reverse stock splitAugust 1, 2024 | uk.investing.comWhy Evoke Pharma (EVOK) Stock Is VolatileJuly 31, 2024 | msn.comEvoke Pharma, Inc. Announces Reverse Stock SplitJuly 30, 2024 | globenewswire.com60 Interesting Facts From History That You May Not Find In TextbooksJuly 26, 2024 | msn.com60 Little-Known Fascinating Facts To Awaken Your Interest In HistoryJuly 25, 2024 | msn.comEvoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTIJune 17, 2024 | globenewswire.comEvoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) ConferenceMay 16, 2024 | globenewswire.comEvoke Pharma, Inc.: Evoke Pharma Reports First Quarter 2024 Financial ResultsMay 15, 2024 | finanznachrichten.de Get Evoke Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EVOK and its competitors with MarketBeat's FREE daily newsletter. Email Address Wall Street Icon: “You must get on the right side of this thing” (Ad)I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years. This market shakeup is going to be much more intense. EVOK Media Mentions By Week EVOK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EVOK News Sentiment▼0.000.59▲Average Medical News Sentiment EVOK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EVOK Articles This Week▼32▲EVOK Articles Average Week Get Evoke Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EVOK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DRRX News KALA News DARE News FBRX News LGVN News LPCN News NAII News PLUR News LVTX News ENLV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EVOK) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evoke Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evoke Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EVOK Stock Alerts